New Exact Sciences acquisition completed March 23, 2026 for approximately $20.6 billion, funded primarily through the issuance of $20.0 billion of long-term debt in March 2026
Companies with recent signals that might need your attention.
In Practise Forensics
Surfacing the accounting concerns and leading indicators of trouble in this filing.
Gross margin contracted 3.1pp YoY to 45.9% n Q4 2025, down from 49.0%
Already an In Practise subscriber? Sign in
New Exact Sciences acquisition completed March 23, 2026 for approximately $20.6 billion, funded primarily through the issuance of $20.0 billion of long-term debt in March 2026
Brazil non-income tax: prior ~$400 million potential exposure became $619 million loss recognized as operating expense
Wincanton Divestment classified held-for-sale; recorded $37 million write-down including $4 million goodwill, $21 million customer relationships